LSE - Delayed Quote GBp
Scancell Holdings plc (SCLP.L)
At close: November 7 at 2:45 PM GMT
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Revenue
--
--
5,271.00
--
--
Cost of Revenue
--
--
525.00
--
--
Gross Profit
--
--
4,746.00
--
--
Operating Expense
18,267.00
18,267.00
16,666.00
13,299.00
8,834.00
Operating Income
-18,267.00
-18,267.00
-11,920.00
-13,299.00
-8,834.00
Net Non Operating Interest Income Expense
-734.00
-734.00
-931.00
-1,773.00
-7,971.00
Pretax Income
-9,117.00
-9,117.00
-14,304.00
-6,272.00
-16,805.00
Tax Provision
-3,258.00
-3,258.00
-2,368.00
-1,703.00
-1,328.00
Net Income Common Stockholders
-5,859.00
-5,859.00
-11,936.00
-4,569.00
-15,477.00
Average Dilution Earnings
-8,853.00
-8,853.00
--
--
--
Diluted NI Available to Com Stockholders
-14,712.00
-14,712.00
-11,936.00
-4,569.00
-15,477.00
Basic EPS
-0.01
-0.01
-0.01
-0.00
-0.02
Diluted EPS
-0.01
-0.01
-0.01
-0.00
-0.02
Basic Average Shares
818,271.60
862,484.43
816,051.31
815,535.42
678,892.33
Diluted Average Shares
819,981.78
1,029,794.47
816,051.31
815,535.42
678,892.33
Total Operating Income as Reported
-18,267.00
-18,267.00
-11,920.00
-13,299.00
-8,834.00
Rent Expense Supplemental
123.00
--
--
--
--
Total Expenses
18,267.00
18,267.00
17,191.00
13,299.00
8,834.00
Net Income from Continuing & Discontinued Operation
-5,859.00
-5,859.00
-11,936.00
-4,569.00
-15,477.00
Normalized Income
-12,210.91
-12,210.91
-10,723.54
-10,979.59
-15,477.00
Interest Income
355.00
355.00
284.00
4.00
3.00
Interest Expense
1,089.00
1,089.00
1,215.00
1,777.00
1,651.00
Net Interest Income
-734.00
-734.00
-931.00
-1,773.00
-7,971.00
EBIT
-8,028.00
-8,028.00
-13,089.00
-4,495.00
-15,154.00
EBITDA
-7,062.00
-7,062.00
-12,187.00
-3,755.00
-14,905.00
Reconciled Cost of Revenue
--
--
525.00
--
--
Reconciled Depreciation
966.00
966.00
902.00
740.00
249.00
Net Income from Continuing Operation Net Minority Interest
-5,859.00
-5,859.00
-11,936.00
-4,569.00
-15,477.00
Total Unusual Items Excluding Goodwill
9,884.00
9,884.00
-1,453.00
8,800.00
--
Total Unusual Items
9,884.00
9,884.00
-1,453.00
8,800.00
--
Normalized EBITDA
-16,946.00
-16,946.00
-10,734.00
-12,555.00
-14,905.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
3,532.09
3,532.09
-240.54
2,389.41
--
4/30/2021 - 2/12/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OXB.L Oxford Biomedica plc
417.00
+0.36%
ULTI.OL Ultimovacs ASA
1.8500
0.00%
NYKD.OL Nykode Therapeutics AS
4.2920
+0.42%
SNG.L Synairgen plc
4.8500
+6.36%
FARON.HE Faron Pharmaceuticals Oy
1.9200
+6.90%
ORGS Orgenesis Inc.
1.1800
-1.67%
AVCT.L Avacta Group Plc
50.00
+3.20%
ONT.L Oxford Nanopore Technologies plc
133.10
+1.29%
DTIL Precision BioSciences, Inc.
8.42
+0.24%
BAVA.CO Bavarian Nordic A/S
204.00
+2.00%